STAT Plus: Pfizer’s big data exec on pharma’s ‘arms race’ to partner with companies like Fitbit, 23AndMe, and others
Pharmaceutical giants are hunting for ways to tap into the data from your smart watch, your sleep tracker, and your genetic tests.
Drug makers see that information — part of what’s known as real-world evidence — as a powerful tool to help them hunt for new drug targets and design more efficient clinical trials. And they’re racing to outbid one another for the most desirable data.
Continue to STAT Plus to read the full story…
